118 related articles for article (PubMed ID: 10923826)
1. Studies on adsorption characteristics of bile acids and methotrexate to a new type of anion-exchange resin, colestimide.
Honda Y; Nakano M
Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):978-81. PubMed ID: 10923826
[TBL] [Abstract][Full Text] [Related]
2. Effect of colestimide on absorption of unconjugated bile acids in the rat jejunum.
Onishi T; Sano N; Takikawa H
J Gastroenterol Hepatol; 2002 Jun; 17(6):697-701. PubMed ID: 12100616
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ileal bile acid absorption by colestimide.
Takeuchi A; Sano N; Takikawa H
J Gastroenterol Hepatol; 2003 May; 18(5):548-53. PubMed ID: 12702047
[TBL] [Abstract][Full Text] [Related]
4. Effect of colestimide on intestinal absorption of ursodeoxycholic acid in men.
Takikawa H; Ogasawara T; Sato A; Ohashi M; Hasegawa Y; Hojo M
Int J Clin Pharmacol Ther; 2001 Dec; 39(12):558-60. PubMed ID: 11770838
[TBL] [Abstract][Full Text] [Related]
5. Colestimide: the efficacy of a novel anion-exchange resin in cholestatic disorders.
Matsuzaki Y
J Gastroenterol Hepatol; 2002 Nov; 17(11):1133-5. PubMed ID: 12453270
[No Abstract] [Full Text] [Related]
6. Effect of oral colestimide on the elimination of high-dose methotrexate in patients with primary central nervous system lymphoma--case report.
Makino K; Kochi M; Nakamura H; Kuroda J; Honda Y; Ushio Y; Kuratsu J
Neurol Med Chir (Tokyo); 2005 Dec; 45(12):650-2. PubMed ID: 16377955
[TBL] [Abstract][Full Text] [Related]
7. Adsorption of methotrexate and calcium leucovorin onto cholestyramine in vitro.
Merino-Sanjuán M; Carrera A; Monte E; Jiménez-Torres NV
Int J Pharm; 2004 Jul; 278(2):283-91. PubMed ID: 15196633
[TBL] [Abstract][Full Text] [Related]
8. Rapid improvement of icterus and pruritus by the oral administration of colestimide in two cases of drug-induced hepatitis.
Tani M; Hayashi Y; Okamoto S; Yokohama S; Inaba M; Kubota H; Nakamura K
Intern Med; 2001 Nov; 40(11):1098-103. PubMed ID: 11757763
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
Kobayashi M; Ikegami H; Fujisawa T; Nojima K; Kawabata Y; Noso S; Babaya N; Itoi-Babaya M; Yamaji K; Hiromine Y; Shibata M; Ogihara T
Diabetes; 2007 Jan; 56(1):239-47. PubMed ID: 17192488
[TBL] [Abstract][Full Text] [Related]
10. Effects of colestimide and/or Bofu-tsusho-san on plasma and liver lipids in mice fed a high-fat diet.
Sakamoto S; Takeshita S; Sassa S; Suzuki S; Ishikawa Y; Kudo H
In Vivo; 2005; 19(6):1029-33. PubMed ID: 16277017
[TBL] [Abstract][Full Text] [Related]
11. Effects of bile-acid-binding resin (colestimide) on blood glucose and visceral fat in Japanese patients with type 2 diabetes mellitus and hypercholesterolemia: an open-label, randomized, case-control, crossover study.
Suzuki T; Oba K; Igari Y; Watanabe K; Matsumura N; Futami-Suda S; Ouchi M; Suzuki K; Sekimizu K; Kigawa Y; Nakano H
J Diabetes Complications; 2012; 26(1):34-9. PubMed ID: 22240263
[TBL] [Abstract][Full Text] [Related]
12. Colestimide, an anion exchange resin agent, can decrease the number of LDL particles without affecting their size in patients with hyperlipidemia.
Kishimoto N; Fujii S; Chiba H; Sakuma I; Tsutsui H
J Cardiol; 2010 Jan; 55(1):65-8. PubMed ID: 20122550
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of unconjugated bile acids on the enterohepatic circulation of methotrexate.
Said HM; Strum WB; Hollander D
J Pharmacol Exp Ther; 1984 Dec; 231(3):660-4. PubMed ID: 6502520
[TBL] [Abstract][Full Text] [Related]
14. Effect of pore structure on the removal of clofibric acid by magnetic anion exchange resin.
Tan L; Shuang C; Wang Y; Wang J; Su Y; Li A
Chemosphere; 2018 Jan; 191():817-824. PubMed ID: 29080542
[TBL] [Abstract][Full Text] [Related]
15. Research on adsorption of Cr(Ⅵ) by Poly-epichlorohydrin-dimethylamine (EPIDMA) modified weakly basic anion exchange resin D301.
Zang Y; Yue Q; Kan Y; Zhang L; Gao B
Ecotoxicol Environ Saf; 2018 Oct; 161():467-473. PubMed ID: 29909316
[TBL] [Abstract][Full Text] [Related]
16. Bile acid binding and hypocholesterolemic activity of a new anion exchange resin from 2-methylimidazol and epichlorohydrin.
Toda H; Kihara K; Hashimoto M; Mizogami S
J Pharm Sci; 1988 Jun; 77(6):531-3. PubMed ID: 3171935
[TBL] [Abstract][Full Text] [Related]
17. Bile acid binding resin improves metabolic control through the induction of energy expenditure.
Watanabe M; Morimoto K; Houten SM; Kaneko-Iwasaki N; Sugizaki T; Horai Y; Mataki C; Sato H; Murahashi K; Arita E; Schoonjans K; Suzuki T; Itoh H; Auwerx J
PLoS One; 2012; 7(8):e38286. PubMed ID: 22952571
[TBL] [Abstract][Full Text] [Related]
18. Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia.
Yamakawa T; Takano T; Utsunomiya H; Kadonosono K; Okamura A
Endocr J; 2007 Feb; 54(1):53-8. PubMed ID: 17102570
[TBL] [Abstract][Full Text] [Related]
19. Colestimide can be used as a phosphate binder to treat uraemia in end-stage renal disease patients.
Date T; Shigematsu T; Kawashita Y; Satake N; Morita K
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii90-3. PubMed ID: 12771311
[TBL] [Abstract][Full Text] [Related]
20. Effect of competing anions on binding of bile salts by cholestyramine.
Kos R; White JL; Hem SL; Borin MT
Pharm Res; 1991 Feb; 8(2):238-41. PubMed ID: 2023874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
